Use the journals feature with a free QxMD account.
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign Up#21
JOURNAL ARTICLE
Marilyn A Almora-Orellana, Jannipsa Espinoza-Guevara
No abstract text is available yet for this article.
February 15, 2024: Archivos de Cardiología de México
#22
JOURNAL ARTICLE
Jaime A Gómez-Rosero, Laura Duque-González, Juan M Senior-Sánchez
This review provides an overview of the efficacy and safety of renal sympathetic denervation as a therapeutic approach for resistant hypertension. While the initial enthusiasm was sparked by the results of early clinical trials, it was dampened by the findings of the Symplicity HTN-3 study. However, recent advances in catheter technology and more refined patient selection criteria have yielded more promising results. Subsequent studies, such as SPYRAL HTN-OFF MED and RADIANCE II, demonstrated significant reductions in blood pressure, even in patients with mild to moderate hypertension...
February 15, 2024: Archivos de Cardiología de México
#23
JOURNAL ARTICLE
Werner Schlie-Villa, Gerson Marín-Rendón, Ximena Ayala-Huerta, Juan S Carrillo-Calzontzi, Flor T Rosas-Aragón
No abstract text is available yet for this article.
February 15, 2024: Archivos de Cardiología de México
#24
JOURNAL ARTICLE
Emmanuel A Lazcano-Díaz, Uriel Encarnación-Martínez, Cristhian J Gaytán-García, Daniel Manzur-Sandoval, Francisco J González-Ruiz, Edgar García-Cruz, Ángel Ramos-Enríquez, Luis E Santos-Martínez, Luis A Cota-Apodaca, Benjamín I Hernández-Mejía, Dania E Escamilla-Ríos, Gustavo Rojas-Velasco
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subtype of pulmonary hypertension characterized by the obstruction of pulmonary arteries secondary to chronic thromboembolism. Pulmonary thromboendarterectomy surgery (PTE) is the main treatment for patients with CTEPH, as it removes the chronic thrombi from the pulmonary arteries. Pulmonary reperfusion syndrome is a common complication of the surgery, which involves the development of pulmonary edema in the area where blood perfusion improves after the surgery...
February 15, 2024: Archivos de Cardiología de México
#25
JOURNAL ARTICLE
Raúl E Ríos-Méndez, María E Araúz-Martínez, Jorge A Oliveros-Rivero, Yeiber J Crespo-Gutiérrez, Yesenia W Pérez-Vite
BACKGROUND AND OBJECTIVE: To communicate the experience in an Andean country with the OcclutechTM Duct Occluder device for the closure of patent ductus arteriosus. METHOD: observational, retrospective, cross-sectional study with basic statistical analysis. Period: December/2014 to December/2022. Data: medical chart, reports of catheterization. RESULTS: Forty-six patients, female 71.3%, male 28.7%; age: 0.6-38 years-old (median [Me]: 5.2); weight: 6...
February 15, 2024: Archivos de Cardiología de México
#26
JOURNAL ARTICLE
Juan Calderón-Colmenero, Diego B Ortega-Zhindón, Nonanzit Pérez-Hernández, José M Rodríguez-Pérez, Jorge L Cervantes-Salazar
No abstract text is available yet for this article.
February 15, 2024: Archivos de Cardiología de México
#27
JOURNAL ARTICLE
Gregorio Peña-Rodríguez, Ana G Gallardo-Hernández, Cindy G Llerena-García, Martha A Maldonado-Burgos, Eloísa Escobedo-Naurisa
OBJECTIVE: To determine the impact of diabetes on cardiovascular risk in patients with dyslipidemia. METHOD: Observational, cross-sectional and comparative study in which cardiovascular risk was determined at 10 years in 100 patients with dyslipidemia, of these, 50 non-diabetic patients and 50 diabetic patients. RESULTS: Both groups had similar characteristics in terms of age, blood pressure figures, average body mass index, and HDL and LDL levels...
February 12, 2024: Archivos de Cardiología de México
#28
JOURNAL ARTICLE
Ramiro Monzón-Herrera, Federico Listorti, Natalia Vensentini, Javier Mariani
OBJECTIVE: The treatment with phosphodiesterase-5 (PDE-5) inhibitors was postulated in heart failure (HF). We conducted a systematic review and a meta-analysis on their beneficial and adverse effects in patients with HF. METHOD: A meta-analysis of randomized trials evaluating the chronic use of PDE-5 inhibitors in patients with HF was conducted. Endpoints included death, HF hospitalizations, functional capacity, pulmonary pressures, quality of life, and adverse effects...
February 8, 2024: Archivos de Cardiología de México
#29
JOURNAL ARTICLE
Gustavo Inzunza-Cervantes, José A Cigarroa-Lopéz, Antonio Tepayotl-Aponte, Raúl Martínez-Castro, José A Magaña-Serrano, Juan B Ivey-Miranda
No abstract text is available yet for this article.
February 8, 2024: Archivos de Cardiología de México
#30
JOURNAL ARTICLE
Albina Aldomà-Balasch, Marta Z Zielonka, Pedro K Rivera-Aguilar, Ramón Bascompte-Claret
In the presence of the left ventricle hypertrophy (LVH), the differential diagnosis with hypertrophic cardiomyopathy (HCM) or some phenocopy must be always considered, which can be easily suspected when the hypertrophy is markedly asymmetric. However, when the hypertrophy is homogeneous, especially if the patient has concomitant hypertension, it may be a challenge to distinguish between hypertensive and HCM, although some clinical features may help us to suspect it. In addition, patients with HCM may present with exertional angina due to microcirculation involvement in the setting of the hypertrophy itself or dynamic obstruction in the left ventricular outflow tract, but in some cases, the presence of concomitant coronary artery disease must be suspected as the cause of angina, especially if the patient has an intermediate or high-risk probability of having ischemic heart disease...
February 8, 2024: Archivos de Cardiología de México
#31
JOURNAL ARTICLE
Ulises Gómez-Álvarez, Denisse A Razo-Ortega, Amada Álvarez-Sangabriel, Juan C de la Fuente-Mancera, Carlos A Guizar-Sánchez
No abstract text is available yet for this article.
February 8, 2024: Archivos de Cardiología de México
#32
JOURNAL ARTICLE
Laura V López-Gutiérrez, María I Mora-Atehortúa, Sebastián Peláez-García, Fabián A Jaimes-Barragán, Yesid A Saavedra-González, Diego A Ossa-Estrada, Juan P Villegas-Molina, Andrés H Polo-Guzmán, Clara I Saldarriaga-Giraldo
BACKGROUND: Because the benefits and risks of anticoagulation are still unknown in patients with atrial fibrillation (AF) and with chronic kidney disease (CKD) on hemodialysis. OBJECTIVE: The aim of this study was to estimate whether the consumption of anticoagulants was associated with a difference in the frequency of thrombosis of any site, major bleeding and mortality, in adults with both diseases. METHOD: A retrospective cohort study was carried out in four high complexity centers...
February 7, 2024: Archivos de Cardiología de México
#33
JOURNAL ARTICLE
Hector I Michelena, Alessandro Della Corte, Arturo Evangelista, Joseph J Maleszewski, William D Edwards, Mary J Roman, Richard B Devereux, Borja Fernández, Federico M Asch, Alex J Barker, Lilia M Sierra, Laurent de Kerchove, Susan M Fernandes, Paul W M Fedak, Evaldas Girdauskas, Victoria Delgado, Suhny Abbara, Emmanuel Lansac, Siddharth K Prakash, Malenka M Bissell, Bogdan A Popescu, Michael D Hope, Marta Sitges, Vinod H Thourani, Phillippe Pibarot, Krishnaswamy Chandrasekaran, Patrizio Lancellotti, Michael A Borger, John K Forrest, John Webb, Dianna M Milewicz, Raj Makkar, Martin B Leon, Stephen P Sanders, Michael Markl, Victor A Ferrari, William C Roberts, Jae-Kwan Song, Philipp Blanke, Charles S White, Samuel Siu, Lars G Svensson, Alan C Braverman, Joseph Bavaria, Thoralf M Sundt, Gebrine El Khoury, Ruggero de Paulis, Maurice Enriquez-Sarano, Jeroen J Bax, Catherine M Otto, Hans-Joachim Schäfers
This consensus of nomenclature and classification for congenital bicuspid aortic valve and its aortopathy is evidence-based and intended for universal use by physicians (both pediatricians and adults), echocardiographers, advanced cardiovascular imaging specialists, interventional cardiologists, cardiovascular surgeons, pathologists, geneticists, and researchers spanning these areas of clinical and basic research. In addition, as long as new key and reference research is available, this international consensus may be subject to change based on evidence-based data1...
February 7, 2024: Archivos de Cardiología de México
#34
JOURNAL ARTICLE
Kristian Rivera, Marta Zielonka, Tania Ramírez-Martínez, Nuria Pueyo-Balsells, Diego Fernández-Rodríguez
No abstract text is available yet for this article.
February 2, 2024: Archivos de Cardiología de México
#35
JOURNAL ARTICLE
Gonzalo M Fernández-Villar, Mauricio Delgado-Gaete, Marco A Borja-Yenchong, Emiliano Rossi, Elsa M Nucifora, Vadim Kotowicz, Rodolfo Pizarro
INTRODUCTION: Anemia is associated with increased mortality in patients undergoing major surgeries. OBJECTIVE: The aim of this study is to evaluate the prevalence of anemia in the preoperative period of cardiovascular surgery, its postoperative incidence and its evolution during the first month in our setting. METHODS: A prospective cohort study was carried out in which all patients undergoing central cardiovascular surgery operated during the period 09/01/2021-09/01/2022 in a university hospital were included...
February 2, 2024: Archivos de Cardiología de México
#36
JOURNAL ARTICLE
Diego R Campos-Franco, Héctor González-Pacheco, Alexandra Arias-Mendoza
OBJECTIVE: To assess the association between coronary collateral circulation and ventricular contractile function in patients with non-reperfused acute myocardial infarction. METHOD: A retrospective and descriptive clinical study was conducted on patients with ST-elevation myocardial infarction (STEMI) at a reference cardiovascular center, from January 2006 to December 2022. Coronary angiographies and echocardiograms were reviewed to evaluate coronary collateral circulation and ventricular function, respectively...
February 2, 2024: Archivos de Cardiología de México
#37
JOURNAL ARTICLE
Jorge Nara-Sauceda, Mario Moreno-Pacheco, Jesica Patiño-García
OBJECTIVE: To determine the clinical-epidemiological characteristics, diagnostic feasibility of home respiratory polygraphy and treatment of patients with suspected obstructive sleep apnea (OSA) at cardiovascular risk. METHODS: An observational, cross-sectional, descriptive study was conducted in patients seen in a cardiology outpatient service with suspected OSA, from January 2015 to December 2019. The information was obtained from medical records, and a descriptive statistical analysis was applied to this information...
February 2, 2024: Archivos de Cardiología de México
#38
JOURNAL ARTICLE
Jorge Álvarez de la Cadena-Sillas, Enrique Asensio-Lafuente, David Martínez-Dunker, Agustín Urzúa-Gonzalez, Manuel Celaya-Cota, Luisa F Aguilera-Mora, José Lainez-Zelaya, Lillian Hernández-Garcia, Erik H González-Cruz
Sudden cardiac death is a common occurrence. Out-of-hospital cardiac arrest is a global public health problem suffered by ≈3.8 million people annually. Progress has been made in the knowledge of this disease, its prevention, and treatment; however, most events occur in people without a previous diagnosis of heart disease. Due to its multifactorial and complex nature, it represents a challenge in public health, so it led us to work in a consensus to achieve the implementation of cardioprotected areas in Mexico as a priority mechanism to treat these events...
February 2, 2024: Archivos de Cardiología de México
#39
JOURNAL ARTICLE
David J Sánchez-Amaya, Mateo D Gutiérrez-Castañeda, Diego Araiza-Garaygordobil, Alexandra Arias-Mendoza
No abstract text is available yet for this article.
February 2, 2024: Archivos de Cardiología de México
#40
JOURNAL ARTICLE
Arturo Sáenz-San Martín, Pablo Méndez-Ocampo, Iván Gutiérrez-Moctezuma, Luis M Amezcua-Guerra
Inflammation is an important pathogenic factor for the development of atherosclerotic cardiovascular disease. Currently, the most frequently used biomarker reflecting systemic inflammation is C-reactive protein (CRP), an acute-phase protein produced primarily by hepatocytes under the influence of interleukin-6, interleukin-1 beta, and tumor necrosis factor. Growing evidence from epidemiological studies has shown a robust association between elevated serum or plasma CRP concentrations and the incidence of a first cardiovascular adverse event (including acute myocardial infarction, ischemic stroke, and sudden cardiac death) in the general population, as well as recurrence of major adverse cardiovascular events among patients with established disease...
February 2, 2024: Archivos de Cardiología de México
Make the most of Read.
Download the mobile app.
Download the mobile app.
Fetching more papers... 
